E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance
July 13, 2021 08:00 ET | electroCore, Inc.
Second-Quarter 2021 revenue expected to be approximately $1.3 millionNet cash used to fund operations in the second quarter 2021 of approximately $3.2 millionFollow on offering subsequent to June 30,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
July 09, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, July 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, CEO will present a company...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Proposed Public Offering of Common Stock
June 29, 2021 16:01 ET | electroCore, Inc.
ROCKAWAY, NJ, June 29, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that it intends to offer and...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation
June 24, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 24, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper on...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China
June 23, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into an agreement with Kromax...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Join Russell Microcap® Index
June 16, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 16, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today the addition of its stock to the broad-market...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Completes Sale of $1.4 Million of NJ NOL Tax Benefits 
June 09, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has completed the sale of $1.4 million of...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinson’s Disease Patients
June 02, 2021 07:30 ET | electroCore, Inc.
ROCKAWAY, N.J., June 02, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Present at Investor Conferences in June
May 26, 2021 07:30 ET | electroCore, Inc.
ROCKAWAY, NJ, May 26, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today that its management team will present a several...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache
May 04, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, May 04, 2021 (GLOBE NEWSWIRE) -- -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the U.S. Department of Veterans Affairs is...